EZH2-mediated epigenetic suppression of SH3BGRL potently inhibits lung cancer progression
- 22 February 2021
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 548, 53-59
- https://doi.org/10.1016/j.bbrc.2021.02.056
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- EZH2 Is Essential for Glioblastoma Cancer Stem Cell MaintenanceCancer Research, 2009
- Polycomb silencers control cell fate, development and cancerNature Reviews Cancer, 2006
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- Crystal structure of human SH3BGRL protein: The first structure of the human SH3BGR family representing a novel class of thioredoxin fold proteinsProteins: Structure, Function, and Bioinformatics, 2005
- Role of Histone H3 Lysine 27 Methylation in Polycomb-Group SilencingScience, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- A Novel Human Homologue of the SH3BGR Gene Encodes a Small Protein Similar to Glutaredoxin 1 of Escherichia coliBiochemical and Biophysical Research Communications, 2001
- Identification and Characterization of a New Human Gene Encoding a Small Protein with High Homology to the Proline-Rich Region of the SH3BGR GeneBiochemical and Biophysical Research Communications, 1998
- SH2/SH3 signaling proteinsCurrent Opinion in Genetics & Development, 1994